Gingko Supplement Adulteration Points To Broader Problem For FDA – CSPI
This article was originally published in The Rose Sheet
Executive Summary
Nutrition and food safety watchdog group asks FDA to enforce against marketers of ginkgo supplements after ConsumerLab.com found that six of 10 ginkgo supplements it tested contained either less of the herb than advertised or different and cheaper plant material.
You may also be interested in...
Economic Adulteration Underscored In GAO Memory Supplements Study
Audit finds two of three memory supplements tested contain none or lower levels of active supplement than stated on labeling. In a report for current and previous ranking minority members of Senate Special Committee on Aging, GAO points to continuing issues with economic adulteration for gingko biloba.
Health And Wellness Industry Regulatory And Litigation News
FTC ends 9-party supplement claims enforcement with three last settlements; ginkgo class action against Nature’s Bounty dismissed; and litigation dismissed when suspect sexual enhancement supplements removed from website.
Labdoor Closes Door To Jarrow's Challenge In A NAD Review
Labdoor, which offers online sales of products in addition to publishing rankings within product categories based on its evaluations, declined to offer evidence for NAD's review of challenges by Jarrow Formulas.